State Street’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,822
Closed -$28.8K 4288
2024
Q4
$28.8K Hold
4,822
﹤0.01% 4191
2024
Q3
$47.1K Sell
4,822
-2,975
-38% -$29K ﹤0.01% 4112
2024
Q2
$160K Sell
7,797
-21,260
-73% -$435K ﹤0.01% 3880
2024
Q1
$1.31M Buy
29,057
+1,536
+6% +$69.3K ﹤0.01% 3400
2023
Q4
$1.3M Buy
27,521
+1,905
+7% +$89.9K ﹤0.01% 3425
2023
Q3
$1.04M Sell
25,616
-103,896
-80% -$4.21M ﹤0.01% 3522
2023
Q2
$13.8M Buy
129,512
+19,469
+18% +$2.07M ﹤0.01% 2465
2023
Q1
$32.9M Buy
110,043
+87,007
+378% +$26M ﹤0.01% 1911
2022
Q4
$7.92M Sell
23,036
-69
-0.3% -$23.7K ﹤0.01% 2834
2022
Q3
$4.37M Buy
23,105
+276
+1% +$52.2K ﹤0.01% 3132
2022
Q2
$4.82M Sell
22,829
-64,718
-74% -$13.7M ﹤0.01% 3122
2022
Q1
$29.3M Buy
87,547
+3,478
+4% +$1.16M ﹤0.01% 2125
2021
Q4
$27.3M Buy
84,069
+1,032
+1% +$336K ﹤0.01% 2237
2021
Q3
$40.3M Sell
83,037
-8,158
-9% -$3.96M ﹤0.01% 1969
2021
Q2
$42.4M Buy
91,195
+11,451
+14% +$5.32M ﹤0.01% 1973
2021
Q1
$55.1M Sell
79,744
-24,881
-24% -$17.2M ﹤0.01% 1672
2020
Q4
$77.3M Buy
104,625
+23,759
+29% +$17.6M ﹤0.01% 1353
2020
Q3
$56.1M Buy
80,866
+19,967
+33% +$13.9M ﹤0.01% 1372
2020
Q2
$51.7M Buy
60,899
+53,012
+672% +$45M ﹤0.01% 1445
2020
Q1
$2.82M Buy
7,887
+1,640
+26% +$586K ﹤0.01% 2905
2019
Q4
$1.46M Buy
6,247
+946
+18% +$221K ﹤0.01% 3339
2019
Q3
$597K Buy
5,301
+1,292
+32% +$146K ﹤0.01% 3478
2019
Q2
$526K Buy
+4,009
New +$526K ﹤0.01% 3504